Indiana’s life sciences companies accessed more than $9 billion to grow innovation in 2020

Facebook
Twitter
This post was originally published on this site

In 2020, Indiana’s life sciences companies accessed over $9 billion in capital to grow and support innovation. The funding comes from a variety of sources including Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) awards, venture capital, initial public offerings and related public offerings, and mergers and acquisitions. BioCrossroads’ report, Indiana Life Sciences Capital 2020, provides details on the funding events throughout the year.

The post Indiana’s life sciences companies accessed more than $9 billion to grow innovation in 2020 appeared first on BioCrossroads.